Public Health England
Weekly national flu and COVID-19 surveillance reports published
National influenza and COVID-19 report, monitoring coronavirus (COVID-19) activity, seasonal flu and other seasonal respiratory illnesses.
The main points from this week’s national influenza and COVID-19 surveillance report are:
Surveillance indicators suggest that at a national level COVID-19 activity decreased in week 14 of 2021.
Case rates have fallen across all age groups.
Case rates continue to be highest in those aged 10 to 19, with a case rate of 42.8 per 100,000 population.
The lowest case rates continue to be in those aged 70 to 79, with a rate of 7.5 per 100,000 population.
Case rates per 100,000 have fallen across all regions and remain highest in Yorkshire and the Humber, at 57.4.
Case rates per 100,000 are lowest in the South West, with a rate of 12.8.
The number of acute respiratory infection incidents (suspected outbreaks) in England was 92 in week 14, compared to 140 in the previous week.
Seroprevalence data indicates that around 53.7% of the population have antibodies to SARS-CoV-2 from either infection or vaccination, compared to 15% from infection alone.
In the 70 to 84 years age group, around 97.7% had antibodies from either infection or vaccination compared to 4.8% from infection alone.
The hospital admission rate for COVID-19 has fallen – it was 1.85 per 100,000 in week 14, compared to 2.11 per 100,000 in the previous week.
Hospital admission rates for COVID-19 are highest in Yorkshire and the Humber, with a rate of 3.36.
The highest hospital admission rates continue to be those aged 85 and above.
Dr Yvonne Doyle, Medical Director at Public Health England yesterday said:
Our efforts over many months have helped to suppress the virus, but I want to stress how even more vital it is to follow guidance as we go back to doing the things we have missed for so long. Many countries, including those on our doorstep, are facing another dangerous wave. Following guidance continues to be a matter of high protection for us all.
About half of us do not yet have protective antibodies from either recent infection or vaccination, so when you are offered the vaccine, do not delay. It has already saved more than 10,000 lives.
Latest News from
Public Health England
JCVI advises on COVID-19 vaccine for people aged under 4007/05/2021 12:10:00
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40.
COVID-19 in schools: study shows drop in infections04/05/2021 16:10:00
Round 4 of the Schools Infection Survey (SIS) shows a significant drop in the number of secondary school pupils and staff testing positive for coronavirus (COVID-19).
One dose of COVID-19 vaccine can cut household transmission by up to half29/04/2021 09:25:00
A new study by Public Health England (PHE) has shown that one dose of the COVID-19 vaccine reduces household transmission by up to half.
Public urged to report sightings of tree pest oak processionary moth caterpillars20/04/2021 10:10:10
The Forestry Commission calls on public to report sightings of tree pest oak processionary moth caterpillars.
JCVI issues new advice on COVID-19 vaccination for pregnant women19/04/2021 10:10:10
The JCVI has advised that pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.
COVID-19 vaccines have prevented 10,400 deaths in older adults12/04/2021 10:10:10
PHE analysis suggests the UK COVID-19 vaccination programme has so far prevented thousands of deaths in those aged 60 and above.
New JCVI advice on use of the AstraZeneca COVID-19 vaccine08/04/2021 14:05:00
The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots.
Dr Jenny Harries marks official launch of UK Health Security Agency06/04/2021 11:10:00
New chief executive marked her first day with a visit to Colindale laboratories in North London, accompanied by Health Secretary Matt Hancock.